Literature DB >> 27296849

Rule of accumulation of enrofloxacin in Acipenser baerii and drug-induced damage to the tissues.

Di Wang1, Shaowu Li1, Tongyan Lu2.   

Abstract

Enrofloxacin (ENX) has been widely used in the prevention and control of bacterial diseases in sturgeon aquaculture due to its characteristics of wide antibacterial spectrum, strong antibacterial activity, less toxicity and fewer side effects, rapid action, extensive in vivo distribution, and little cross-resistance with other antibiotics. However, the spinal abnormality was found in Acipenser baerii soon after ENX administration, which resulted an "S"-shaped curvature of the spine and retarded fish growth. It was still not clear whether ENX could cause spinal abnormality in sturgeons by now. The aim of this work was to determine the accumulation rule and toxicity of ENX to A. baerii when used at a high dose and/or unusually long durations. Here, ENX was orally given to A. baerii for 3-5 d continuously at the dosage of 0, 20, 40, and 80 mg/kg once daily, respectively. The accumulation of ENX in blood, liver, kidney, and cartilage was detected after withdrawal, and the tissues were made into sections for morphological examination. The results showed that the levels of ENX increased in the four tissues with the increase of dose and duration, and the ENX level in serum was far lower than that in other tissues. At 240 h, ENX levels in the four tissues decreased significantly. The histology indicated that the liver, kidney, and cartilage began to show structural damages at 5 d after withdrawal of 40 mg/kg ENX. The damage was aggravated at 3-5 d after withdrawal of 80 mg/kg ENX. At 240 h, the damaged tissues showed signs of recovery. These results suggested that ENX should be no more than 40 mg/kg and that exposure time should not be greater than 5 d to prevent liver, kidney, and cartilage damage. More attention should be paid to the impact of ENX on the occurrence and development of chondrocytes in juvenile A. baerii and the potential damage to the cartilage.
© 2016 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Acipenser baerii; Enrofloxacin; rule of accumulation; toxicity

Mesh:

Substances:

Year:  2016        PMID: 27296849      PMCID: PMC5068456          DOI: 10.1177/1535370216654995

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  8 in total

1.  Multiple route and dose pharmacokinetics of enrofloxacin in juvenile Atlantic salmon.

Authors:  D A Stoffregen; G A Wooster; P S Bustos; P R Bowser; J G Babish
Journal:  J Vet Pharmacol Ther       Date:  1997-04       Impact factor: 1.786

2.  Reservoir of quinolone residues in fish.

Authors:  I Steffenak; V Hormazabal; M Yndestad
Journal:  Food Addit Contam       Date:  1991 Nov-Dec

Review 3.  Pathogenesis of quinolone-induced arthropathy: a review of hypotheses.

Authors:  T Maślanka; J J Jaroszewski; M Chrostowska
Journal:  Pol J Vet Sci       Date:  2004       Impact factor: 0.821

4.  Pharmacokinetics of ciprofloxacin in ponies.

Authors:  P M Dowling; R C Wilson; J W Tyler; S H Duran
Journal:  J Vet Pharmacol Ther       Date:  1995-02       Impact factor: 1.786

5.  Shark cartilage contains inhibitors of tumor angiogenesis.

Authors:  A Lee; R Langer
Journal:  Science       Date:  1983-09-16       Impact factor: 47.728

6.  Clinical toxicological aspects of fluoroquinolones.

Authors:  Ralf Stahlmann
Journal:  Toxicol Lett       Date:  2002-02-28       Impact factor: 4.372

7.  Pharmacokinetics of enrofloxacin in fingerling rainbow trout (Oncorhynchus mykiss).

Authors:  P R Bowser; G A Wooster; J St Leger; J G Babish
Journal:  J Vet Pharmacol Ther       Date:  1992-03       Impact factor: 1.786

8.  Comparative single-dose pharmacokinetics of four quinolones, oxolinic acid, flumequine, sarafloxacin, and enrofloxacin, in Atlantic salmon (Salmo salar) held in seawater at 10 degrees C.

Authors:  B Martinsen; T E Horsberg
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

  8 in total
  2 in total

Review 1.  Enrofloxacin-The Ruthless Killer of Eukaryotic Cells or the Last Hope in the Fight against Bacterial Infections?

Authors:  Łukasz Grabowski; Lidia Gaffke; Karolina Pierzynowska; Zuzanna Cyske; Marta Choszcz; Grzegorz Węgrzyn; Alicja Węgrzyn
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

2.  Development and Validation of a Reproducible and Label-Free Surface Plasmon Resonance Immunosensor for Enrofloxacin Detection in Animal-Derived Foods.

Authors:  Mingfei Pan; Shijie Li; Junping Wang; Wei Sheng; Shuo Wang
Journal:  Sensors (Basel)       Date:  2017-08-30       Impact factor: 3.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.